-

Form 8.3 - INTERNATIONAL PAPER COMPANY

LONDON--(BUSINESS WIRE)-- 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

International Paper Company

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16-07-2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes - DS Smith plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Common Stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

TBC

TBC

6,767,676

1.94

(2) Cash-settled derivatives:

 

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

400,000*

0.115

0

0

 

TOTAL:

400,000*

0.115

6,767,676

1.94

All interests and all short positions should be disclosed.

*This long position relates to a reverse collar transaction. See supplemental form 8 for full details

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

Common Stock

Sale

8

44.76

Common Stock

Sale

33

44.86

Common Stock

Sale

36

44.24

Common Stock

Sale

38

44.79

Common Stock

Sale

42

45.40

Common Stock

Sale

46

44.77

Common Stock

Sale

55

44.44

Common Stock

Sale

75

44.16

Common Stock

Sale

75

44.21

Common Stock

Sale

76

44.82

Common Stock

Sale

82

44.77

Common Stock

Sale

100

44.08

Common Stock

Sale

100

44.20

Common Stock

Sale

100

44.22

Common Stock

Sale

100

44.39

Common Stock

Sale

100

44.54

Common Stock

Sale

100

44.67

Common Stock

Sale

100

44.80

Common Stock

Sale

100

44.87

Common Stock

Sale

100

45.06

Common Stock

Sale

100

45.25

Common Stock

Sale

100

45.43

Common Stock

Sale

100

45.45

Common Stock

Sale

100

45.45

Common Stock

Sale

100

45.52

Common Stock

Sale

100

45.53

Common Stock

Sale

100

45.54

Common Stock

Sale

100

45.56

Common Stock

Sale

116

44.72

Common Stock

Sale

116

45.48

Common Stock

Sale

117

44.97

Common Stock

Sale

119

44.13

Common Stock

Sale

126

45.42

Common Stock

Sale

129

44.96

Common Stock

Sale

132

44.62

Common Stock

Sale

135

44.38

Common Stock

Sale

142

45.15

Common Stock

Sale

156

45.52

Common Stock

Sale

161

44.71

Common Stock

Sale

169

44.95

Common Stock

Sale

200

44.09

Common Stock

Sale

200

44.14

Common Stock

Sale

200

44.22

Common Stock

Sale

200

44.26

Common Stock

Sale

200

44.33

Common Stock

Sale

200

44.48

Common Stock

Sale

200

44.81

Common Stock

Sale

200

44.88

Common Stock

Sale

200

45.02

Common Stock

Sale

200

45.38

Common Stock

Sale

200

45.40

Common Stock

Sale

200

45.41

Common Stock

Sale

201

44.29

Common Stock

Sale

219

45.34

Common Stock

Sale

228

44.84

Common Stock

Sale

230

45.05

Common Stock

Sale

241

44.34

Common Stock

Sale

250

44.43

Common Stock

Sale

253

44.73

Common Stock

Sale

254

44.11

Common Stock

Sale

264

44.75

Common Stock

Sale

300

44.12

Common Stock

Sale

300

44.28

Common Stock

Sale

300

44.45

Common Stock

Sale

300

44.84

Common Stock

Sale

300

45.12

Common Stock

Sale

300

45.48

Common Stock

Sale

300

45.55

Common Stock

Sale

301

44.83

Common Stock

Sale

313

44.70

Common Stock

Sale

318

45.32

Common Stock

Sale

346

45.04

Common Stock

Sale

355

44.93

Common Stock

Sale

363

45.02

Common Stock

Sale

375

45.43

Common Stock

Sale

384

44.85

Common Stock

Sale

403

44.99

Common Stock

Sale

411

45.03

Common Stock

Sale

416

45.21

Common Stock

Sale

422

44.89

Common Stock

Sale

423

45.01

Common Stock

Sale

426

45.27

Common Stock

Sale

434

45.31

Common Stock

Sale

446

45.37

Common Stock

Sale

447

44.74

Common Stock

Sale

456

45.18

Common Stock

Sale

469

45.15

Common Stock

Sale

482

45.56

Common Stock

Sale

505

45.45

Common Stock

Sale

507

45.05

Common Stock

Sale

543

44.90

Common Stock

Sale

549

45.58

Common Stock

Sale

550

44.94

Common Stock

Sale

554

45.23

Common Stock

Sale

577

45.48

Common Stock

Sale

649

45.00

Common Stock

Sale

650

45.36

Common Stock

Sale

673

45.28

Common Stock

Sale

680

45.47

Common Stock

Sale

692

44.80

Common Stock

Sale

740

45.26

Common Stock

Sale

794

45.22

Common Stock

Sale

796

45.54

Common Stock

Sale

804

44.91

Common Stock

Sale

817

45.17

Common Stock

Sale

843

44.98

Common Stock

Sale

864

44.92

Common Stock

Sale

900

44.25

Common Stock

Sale

931

45.16

Common Stock

Sale

980

45.06

Common Stock

Sale

981

45.44

Common Stock

Sale

1005

45.08

Common Stock

Sale

1008

45.30

Common Stock

Sale

1034

45.38

Common Stock

Sale

1119

45.11

Common Stock

Sale

1128

45.11

Common Stock

Sale

1224

45.09

Common Stock

Sale

1337

45.50

Common Stock

Sale

1435

45.24

Common Stock

Sale

1468

45.46

Common Stock

Sale

1561

45.07

Common Stock

Sale

1788

45.44

Common Stock

Sale

1812

45.39

Common Stock

Sale

1833

45.19

Common Stock

Sale

1932

45.14

Common Stock

Sale

2006

45.29

Common Stock

Sale

2190

45.10

Common Stock

Sale

2251

45.13

Common Stock

Sale

2463

45.57

Common Stock

Sale

3296

45.51

Common Stock

Sale

3461

45.33

Common Stock

Sale

4621

45.49

Common Stock

Sale

4860

45.53

Common Stock

Sale

6366

45.52

Common Stock

Sale

7148

45.55

Common Stock

Sale

65835

45.51

Common Stock

Purchase

10

44.79

Common Stock

Purchase

12

44.99

Common Stock

Purchase

15

44.62

Common Stock

Purchase

20

45.00

Common Stock

Purchase

21

44.81

Common Stock

Purchase

25

45.47

Common Stock

Purchase

32

44.77

Common Stock

Purchase

36

44.60

Common Stock

Purchase

36

44.80

Common Stock

Purchase

50

44.12

Common Stock

Purchase

52

44.73

Common Stock

Purchase

55

44.61

Common Stock

Purchase

58

44.13

Common Stock

Purchase

66

44.25

Common Stock

Purchase

72

45.54

Common Stock

Purchase

76

44.23

Common Stock

Purchase

90

44.27

Common Stock

Purchase

92

44.83

Common Stock

Purchase

94

44.84

Common Stock

Purchase

99

45.51

Common Stock

Purchase

100

44.15

Common Stock

Purchase

100

44.24

Common Stock

Purchase

100

44.55

Common Stock

Purchase

100

44.57

Common Stock

Purchase

100

44.75

Common Stock

Purchase

100

45.52

Common Stock

Purchase

120

44.88

Common Stock

Purchase

124

44.42

Common Stock

Purchase

131

45.46

Common Stock

Purchase

136

44.21

Common Stock

Purchase

138

44.90

Common Stock

Purchase

155

44.86

Common Stock

Purchase

167

44.56

Common Stock

Purchase

191

44.44

Common Stock

Purchase

230

44.51

Common Stock

Purchase

255

44.29

Common Stock

Purchase

288

45.53

Common Stock

Purchase

343

45.42

Common Stock

Purchase

430

45.49

Common Stock

Purchase

543

44.87

Common Stock

Purchase

600

45.57

Common Stock

Purchase

783

44.91

Common Stock

Purchase

1025

45.45

Common Stock

Purchase

1297

45.47

Common Stock

Purchase

1715

45.43

Common Stock

Purchase

1730

45.49

Common Stock

Purchase

2042

45.50

Common Stock

Purchase

2244

45.51

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (USD)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (USD)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

 

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

 

0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

17-07-2024

Contact name:

Stuart Brown

Telephone number:

00442070722969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:

Qube Research & Technologies Limited

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

International Paper Company

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Common Stock

Put Option

IP US 07/19/24 P40 Equity

Written

60,000

USD 40

American

07/19/24

Common Stock

Call option

IP US 09/20/24 C50 Equity

Purchase

120,000

USD 50

American

09/20/24

Common Stock

Put Option

IP US07/19/24 P37.5 Equity

Written

60,000

USD 37.5

American

07/19/24

Common Stock

Put Option

IP US 07/19/24 P40 Equity

Written

140,000

USD 40

American

07/19/24

Common Stock

Call Option

IP US 09/20/24 C50 Equity

Purchase

280,000

USD 50

American

09/20/24

Common Stock

Put Option

IP US 07/19/24 P37.5 Equity

Written

140,000

USD 37.5

American

07/19/24

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Contacts

Qube Research & Technologies LTD

Qube Research & Technologies LTD

LSE:0JCB

Release Versions

Contacts

Qube Research & Technologies LTD

More News From Qube Research & Technologies LTD

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
Back to Newsroom